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InTRoduCTIon
Medial sphenoid wing meningiomas (MSWM) constitute a great challenge for neurosurgeons to have complete and safe removal. They are still reported to have the worst neurological functional outcome hindering postoperative quality of life (next to petroclival meningiomas) with highest recurrence rate (2, 8, 18) , partly because of their intricate and intimate relationship with cavernous sinus (CS), arteries of anterior circulation, and optic pathways. As radiosurgery plays an increasing important role in benign tumors, there is much controversy about the indications for aggressive resection of MSWM 1, 5, 13, 20 . It was known that the more aggressive radical resection is achieved, the higher incidence of morbidity and or even mortality would be led to. However, tumor recurrence, which correlates with the extent of resection, is the greatest threat in long-term outcomes (5, 18, 27) . Therefore, it still puzzles neurosurgeons about how to balance the immediate risk of morbidity or even mortality and long-term risk of tumor recurrence.
Many neurosurgeons have observed that the clinical outcomes are even worse in larger tumors than that in smaller ones due to higher incidence of involving neural and vascular structures (6, 11, 14, 17, 22, 36) . While, systemic studies about the correlation of tumor size with clinical characteristics and outcomes especially with long-term outcomes have not been reported in a series of large tumors.
In the present study, we evaluated the long-term outcomes of 127 consecutive cases of MSWM treated with microsurgery by the single neurosurgeon. Special attention will be paid to life quality, neurological functional outcomes, tumor recurrence. We analyzed the correlation of tumor size with clinical characteristics and outcomes.
PATIenTS and MeTHodS
Patient population
127 patients (80 female and 47 male; age ranged from 6 to 79 yr; mean age 44 yr) harboring MSWM were retrospectively analyzed. All patients underwent microsurgery at the Department of Neurosurgery, XiangYa Hospital of Central South University between November 1985 and November 2009 by the senior neurosurgeon (Prof. Xian-rui Yuan). All tumors were confirmed by histological examination and their origin sites were identified on radiological studies and confirmed by intraoperative inspection. However, in case giant tumor, the origin site was often difficult to determine even after intraoperative inspection, but tumors originating from tuberculum sellae, optic canal, orbital roof, planum sphenoidale, middle or lateral aspects of the sphenoid wing were excluded (15) . 12 cases, that may originate from CS but the main parts were extracavernous and mainly involving MSW, were included in this study.
Clinical data
The number of patients presenting clinical symptoms and signs were shown in Table I . The average duration of clinical history was 21.5 months (ranged from 0.25 to 156 Mo). Ophthalmologic examinations including visual acuity (VA) and visual field (VF) were performed in all patients before and after surgery and also during follow up. Among the 74 patients with VA impairment, 65 were unilateral impairment on the side of tumor and the remaining patients were bilateral impairment. The mean duration of VA impairment was 13.8 months (ranged 1 to 72 months). Only 5 patients complained VF deficit, but when tested by computed perimetric exam, 50 patients had VF deficit. The mean KPS score was 73.8 (ranged from 40 to 100).
Radiological findings
Almost all patients underwent evaluation by CT scan preoperatively. Preoperative angiography was conducted in 19 cases; however preoperative embolization was not performed in any cases. Contrast-enhanced MR images were performed in 107 cases. The mean maximum diameter of the tumors calculated on MR images or CT scans was 5.2cm and their distribution is shown in Table II .
Surgical technique
The Orbito-zygomatic frontotemporal approach (in 39 cases), pterional approach (in 85 cases) and subfrontal approach (in 3 cases) were performed for tumor resection. The Orbitozygomatic frontotemporal approach was used at early duration of this study (mainly between 1985 and 1999). With the increasing knowledge of the growth pattern and biological behavior of the tumors and improving surgical technical progress, the pterional approach was enough to remove most of this kind of tumors. Furthermore, it reduced the destruction and injury greatly. In pterional approach, we removed the outer and middle portion of sphenoid wing to the foramen ovale and superior orbital fissure, or even to anterior clinoid process (ACP) if necessary, extradurally. The ACP and optic canal were not removed routinely unless it was observed to be invaded by tumor. In cases, which the vascular or cranial nerves were encased by tumor, dissection of tumor from neurovascular structure was performed by sharp dissection cautiously avoiding violent dragging and direct coagulation as much as possible. We put great emphasis on optic nerve decompression and preservation of nutrient artery of optic nerve. After the tumor was totally removed, the dural attachment was heavily coagulated by monopolar or bipolar. If the tumor had eroded the bone, heavy coagulation with the monopolar was done after total resection of tumor. In cases of tumors involving CS, the tumor was totally removed if the adherence between tumor and ICA, CN was not tight. But if the tumor infiltrated the ICA and CN wildly, the extracavernous portion would be totally removed leaving the intracavernous tumor.
Patients follow-up
All patients were called for their first follow up after 3 months and then 6 months and then 1 year with clinical examinations and contrast-enhanced MR images. If there were no signs of recurrence or progression, they were called for reassessment in 1 to 2 years intervals.
Statistical analysis
All statistical analysis was performed using the SPSS 13.0 software package (Chicago, IL, USA). Chi-square test was used to determine the correlation of tumor sizes with the preand postoperative visual acuity, pre-and postoperative and follow-up KPS score, CS involvement, artery infiltration, ICA encasement, extent of resection, recurrence. All reported p values were two-sided, and a value of p<0.05 was considered statistically significant.
ReSulTS
Tumor removal
Evaluation of MR images and intraoperative inspection revealed the involvement of CS. Tumor infiltrating the lateral wall and even extending into medial compartment of CS was seen in 60 patients. In 19 cases, there was a disappearance of arachnoid dissection plane leading to adherence of tumor to ICA. The relationship with the MCA, the ACA, the optic nerve and the oculomotor nerve is shown in Table III . In our series, no ICA was sacrificed. No ICA injuries that needed reconstruction were encountered. In 10 patients the tumor extended into the optic canal, of which only one needed optic canal opening to remove the tumor, while, others can be pulled out. Of 14 patients (11.0%) who had undergone surgery in other centers and later operated in our department due to tumor recurrence or progression, 10 cases (71.4%) achieved gross total removal and 4 achieved subtotal removal. Tumors in these cases had more rampant infiltration and compact adherence to the vessels which was more difficult to remove.
Pathological findings
According to the WHO Classification 26 , 118 tumors were Grade I meningiomas, and 5 were Grade II, and 4 were Grade III. It's worth noting that 2 cases with Grade I at the first operation underwent malignant transformation and became Grade II or grade III at the time of second surgery. 
Postoperative complications and outcomes
There was no operative mortality. 1 patient suffered from cerebrospinal fluid leakage and after the failure of expectant treatment, he needed a transnasal-endoscopic operation to repair the leakage. Epidural hematoma occurred in 2 patients, 1 recovered by expectant treatment, the other experienced increasing hemicerebral edema and had to undergo decompressive craniectomy. Meningitis occurred in 3 patients. 2 patients suffered pneumonia. 3 patients suffered from injury to the frontal branch of facial nerve.
Postoperative oculomotor nerve palsy occurred in 24 patients, among which 19 were transient and resolved later (Table IV) . New postoperative oculomotor nerve palsy occurred in 19.
Thirteen patients had hemiparesis after surgery including 10 with preoperative hemiparesis, and 9 improved significantly. Hypesthesia of face occurred in 6 patients and improvement occurred in 4 cases. Seizures occurred in 5 patients, among which only a case presented with seizure after surgery. As a whole,, the permanent morbidity was 14.2% (17 of 120 patients).
Patients follow up
Follow-up data including clinical and imaging examinations (contrast-enhanced MR images /CT scans) was available in 120 patients (94.5%). 7 cases lost their follow up. The mean follow-up period was 81.6 months (ranged from 12 to 216 months). In 120 patients, the mean KPS score was 90.6 (ranged from 60 to 100) at 1 year after surgery, which was 83.5 at 10 days after surgery ( During the follow up, 6 died of recurrence or progression of meningiomas, 2 died of unrelated diseases.
Visual outcome
We defined a change in VA as a worsening or improvement of two lines of Snellen acuity or from light-inspection to handmoving, from hand-moving to figures-countering. Among 74 patients with preoperative VA impairment, 42 improved and 30 remained unchanged and 2 worsened. Among other patients with normal VA preoperatively, 2 cases experienced VA deterioration after surgery. In the 4 patients experienced deterioration of VA, the tumor had encased and infiltrated the optic nerve. A secondary deterioration due to tumor recurrence or progression was observed in 5 patients (4.2%) during follow up.
VF charts were available in majority of patients but few had only written description, so only gross changes in the VF were considered significant and subtle changes may be missed. Among patients with preoperative VF deficit, improvement seen in 29 cases (58%) 4 cases who experienced postoperative deterioration of VA also had deterioration of VF. 
dISCuSSIon
Tumor removal
Medial sphenoid wing meningiomas are still challenging lesions to remove totally and safely. The overall outcomes reported recently for MSWM were shown in Table VII . The treatment of meningiomas involving CS has been continuously debated and remains controversial. Some
Recurrence and progression
Tumor recurrence that defined as tumor regrown after gross total resection was observed in 10 patients (10.2%) based on MR images after a mean follow-up of 81.6 months. The mean interval of recurrence was 40.8 months (ranged 6-108 months).
7 patients out of 91 with benign meningiomas (WHO Grade I) were observed recurrence and the rate was 7.7%. 1 patient out of 5 with atypical meningiomas (WHO Grade II) observed recurrence. Both of the 2 patients with malignant meningiomas (WHO Grade III) experienced recurrence. Histopathology grade shown a strong correlation with recurrence(p<0.001).
Of 10 cases with recurrence, 4 underwent second surgery; 5 were treated with gamma knife surgery (GKS), and 1 denied further treatment. Among 4 patients treated with second surgery, 3 were malignant (2 cases undergoing the initial malignancy and 1 was benign in nature with malignant transformation) and had further deteriorated and finally died of a followed recurrence and the other case whose tumor was still benign regained fully daily activity after totally resection without recurrence. In case of 5 patients treated with GKS, the tumor did not regrow in 4 cases and reoccurred in 1 case.
Tumor progression defined as residual tumor regrown after subtotal resection. Among 22 patients with residual tumor, 9 cases underwent GKS treatment and other 13 denied further treatment. 10 cases (45.5%) experienced tumor progression during a mean 7.2 years follow-up time. In cases of patients with GKS, the progression rate was 11% (1 out of 9 cases) and for those without any treatment, the rate was 69.2% (9 out of 13 cases). Eight patients experienced worsening quality of life and deterioration in neurological function significantly.
Overall, 14 patients (5 of recurrence tumors and 9 of residual tumors after subtotal removal) underwent GMK treatment, 12 did not regrow and the control rate was 85.7% for a mean follow up of 90.6 months. 1 patient had visual deterioration and 1 face hypesthesia on the side of tumor after GMK.
Correlation of tumor size with clinical characteristics and outcomes
The patients were divided into three subgroups according to the diameter of tumors (≤4.0cm, 4.1 to 5.9cm, ≥6.0cm). In 36 patients the tumor size was ≤ 4.0cm. It was 4.1 to 5.9cm in 44 patients and ≥6.0cm in 47 patients. Larger tumors were associated with higher incidence of preoperative VA impairment (Table VI, Simpson (34) classified the extent of tumor removal into 5 grades and put great emphasis on dural and bony attachments. In the majority of cases in our series, the dural and bony attachments were heavily coagulated after tumor removal by unipolar or bipolar coagulation instead of resection. Some authors (7, 8) stated that hyperostosis must be considered of bone invasion by tumors and the bony attachment should be removed. In small tumors it was usually accessible, while, in large or giant tumors, the tumor infiltrate wildly and more difficulty may be encountered to remove all of the dural and bony attachments radically which may increase the risk of injury of neural structure and exposure-induced complications. Nakanuma et al. (20) found that there was no statistically difference of recurrence rate between group with bone removal and group without removal. We considered that heavy coagulation of dural can maybe kill most of even all of the tumor cells and can replace radically resection if no signs of erosion of bone inspected at the surgery and images. At a mean follow-up of 81.6 months, the tumor recurrence occurred in 10.2% patients. However, given the small number of cases and as no comparative study was performed, the views must taken with caution and more investigations including longer follow up and a comparative study of larger series should be performed to support this hypothesis.
Neurological functional outcomes
It was reported that complications after surgery were related with the extent of tumor resection. Al-Mefty(2-4) reported authors (6,9,30-32) proposed a radical and aggressive resection whereas, some authors (5, 13, 20, 21, 23, 28, 35) proposed a conservative strategy with or without following radiosurgery. In our series, total removal was achieved in 104 cases (81.2%), and of 60 cases with CS involvement, 47 were achieved total removal. CS involvement limits the extent of tumor removal, but if patients have either severe preoperative CN deficit or minimal intraoperative adherences to the CN or ICA, we think aggressive surgery should be justified and must be performed to low the risk of new recurrence. However, if the neurological deficit is not evident and the tumor encasement and infiltration to the CN or ICA is present with tight adherence, we should take conservative resection to improve functional outcome.
Cerebral ischemia that results from direct injury or secondary spasm of arteries especially important perforating arteries may cause severe neurological defect. Balloon occlusion test (BOT), a safe and effective method to test the patient's tolerance to occlusion of ICA, was useful and gave important information to help the surgeon making the decision in cases that ICA was encased by tumor. However, it was not performed before operation in any patients. In our experience, if the tumor was neither too hard nor seriously infiltrated ICA, it was possible to separate the tumor from ICA safely after ICA was identified. The philosophy of conservative resection was also need to be considered if the total removal was in cost of ICA sacrifices. In our series, no ICA was sacrificed. No ICA injuries that needed reconstruction were encountered. In 9 patients, the ICA and its branches were encased and directly infiltrated by tumor and adherence was very tight; total removal was 
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pathological WHO Grade was significantly impacted on tumor recurrence in our series. In atypical and malignant meningiomas, recurrence is almost always inevitable, therefore, we advocated that WHO Grade II and III was an indicator of adjuvant radiotherapy after tumor removal.
The surgical treatment for recurrence tumor was even more difficult than that in the first time operation (20) . In our series, 14 patients had undergone surgery in other center and experienced recurrence, the rate of total removal (71.4%) was lower than the patients performed the first operation (83.2%). Among the 10 patients who experienced recurrence, 4 underwent a second surgery and 3 died of their tumor which belongs to WHO grade II or III. Recurrence tumors had a higher incidence of directly encroaching the adventitia of ICA and its branches and the tumor rampant infiltrated adjacent structure; furthermore, they may experience pathological malignant transformation. Therefore, the first operation is extremely important and should be aggressive and vigilant.
At the same time we should be careful to treat tumor attachments to minimize recurrence. When tumor residual is inevitable, the radiosurgery treatment should be performed to control the regrowth of tumor, especially in those whose close image follow-up is not possible.
Tumor size
It was reported that difficulty of surgery, extent of tumor removal, associated surgical risks, and patients outcomes are related to the tumor size in meningiomas of suprasellar and parasellar region (6, 11, 14, 17, 22, 36) . Goel et al. (11) proposed a different system for grading ACP meningiomas, in which tumor size was included as an impact factors. They indicated a high risk of surgical failure for those larger than 3 cm (35.3% for this group vs. 0% for smaller tumors). Pamir et al. (22) stated that tumor size should be incorporated into classification scheme for determining clinical and surgical risk. They found that tumor size larger than 2cm may be more unfavourable regarding the extent of resection and outcome than those smaller than 2cm, due to distal adherence to neural structure and vascular. In our series, the tumor size had significant effect on preoperative VA impairment, while, did not significant related to postoperative VA outcome. The tumor impact on preoperative VA by direct and indirect compression or devascularization, therefore, large tumor had more mass effect that led to visual dysfunctions. To our knowledge, the postoperative visual outcome had some more impact factors. Our experience was that the relationship of tumor and optic nerve play the key role in postoperative visual outcomes, such as optic nerve involvement and optic nerve encasement. In all of the 4 patients who experienced VA deterioration postoperatively, the optic nerve was encased by tumor and its nutritional artery was destructed severely. Careful manipulation was also important, while, the tumor size had a minor weight in visual postoperative outcome.
Preoperative and postoperative life quality was associated with tumor size in our series. At the follow-up of 1 year after surgery, no statistic difference of life quality was total removal achieved in 20 cases with morbidity rate of 25% and mortality rate 42.9% in a series of 24 cases. In our series, the permanent morbidity was 14.2% and mostly resulted from neuro-ophthalmological deficit and hemiparesis. Ischemia that results from direct injury or vasospasm of ICA and its branches will lead neurological deficit. Careful manipulation and great caution should be taken to separate the tumor from involved vessels. No direct injury of MCA and ICA occurred in our series, 9 cases of 13 who experienced hemiparalysis after surgery improved significantly at the follow up.
Neurological outcome on long-term follow-up was not usually considered in previous report. Abdel-Aziz et al. (1) reported excellent results in their survey of 38 patients, with a persistent morbidity in 16% and a KPS score > 90 in 89% of their cases 1 year after surgery. Bassiouni et al. (5) reported a deterioration in neurological condition in 14% of 96 cases due to tumor progression for a mean period of 6.9 years follow-up. In our series, 12 (10%) experienced a second life quality deterioration due to tumor recurrence or progression including 6 died of their tumors.
Visual outcome
The past views regarding postoperative visual recovery were quite pessimistic. Although the visual outcome had seen some progress in recent years, the overall outcomes remains unsatisfactory (5, 6, 11, 19 (29) . In our series, the tumor extending into optic nerve canal was encountered in 10 cases, and the tumor can be pulled out in 9 and only in 1 case the tumor infiltrated the optic canal or optic nerve and needed optic canal opening. We consider aggressive skull base approach of clinoidectomy with optic canal unroofing routinely is unnecessary unless the tumor originates from optic canal or infiltrates in optic canal, in which case the tumor can not be pulled out.
Recurrence and progression
Many factors impacted on tumor recurrence of meningiomas reported previously, including tumor sizes, involvement of CS, pathology grade, extent of resection, and peritumoral edema. In our series, 46 patients with CS involvement reached total resection, however 6 (13.3%) experienced recurrence. The recurrence rate of those without CS involvement was 7.5%. It was well documented that tumor recurrence was strongly related to the pathological grade of the meningioma. The found between large tumor and small tumors. Life quality depended on neurological function. Postoperative life quality immediately after surgery was associated with preoperative status. In our series, the extent of resection was correlated with tumor size. Large tumors were more likely experiencing ICA encasement and artery infiltration, which may significantly impact on tumor removal. The tumor size did not correlate with recurrence significantly, partly because in all of the cases we treated the tumor attachment radically and recurrence was greatly impacted by pathological grade.
Radiosurgery
Radiosurgery has proved to be an effective adjuvant therapy in controlling growth of meningiomas and plays a important role in meningiomas involving CS. Actual tumor growth control rate after GMK of CS meningiomas ranged from 91% to 96.5% at 5 years and 82% to 94% at 10 years (10, 12, 13, 16, 23, 24, 35) . In our series, 85.7% patients (12 out of 14 patients) after GMK treatment did not regrow for a mean follow up of 90.6 months and 2 patients had related acceptable complications, including 1 patient had visual deterioration and 1 face hypesthesia on the side of tumor after GMK. Radiosurgery shows acceptable results of long-term tumor control and related complications for small recurrence or residual tumors. The treatment should cover the entire tumor volume with an adequately high radiation dosage to achieve a high tumor control rate (33) . Therefore, if a small piece of tumor has to be left in situ, we should minify the residual tumor volume as long as possible. Careful monitoring of recurrence or progression is also necessary.
ConCluSIonS
The surgical treatment of medial sphenoid wing meningiomas still remains a challenge for neurosurgeons. Simpson Grade II resection had acceptable outcomes associated with minimal recurrence. However, in our experience, the clinoidectomy with optic canal opening routinely was not necessary unless the tumors infiltrated the canal. Tumor recurrence and progression was the major risk in the long run, and the first operation was extremely important and vigilant. At the same time we should be careful to treat the tumor attachments so as to minimize the risk of recurrence. Radiosurgery served as a promising adjuvant therapy for small residual or recurrence tumors. Large tumors do have poorer clinical outcome including visual improvement and KPS score immediately after surgery and encounter more difficulty to removal totally, but, in the long run, the tumor size was not correlated with long-term overall outcomes by our treatment strategy.
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